Postinfarct ventricular septal defect repair: Effect of coronary artery bypass grafting

Between June 1968 and April 1991, 75 patients who had undergone coronary angiography underwent repair of a postinfarction ventricular septal defect. Group 1 (n = 33) includes patients who had two- or three-vessel serious (>75% narrowing) proximal coronary artery disease and underwent complete rev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Annals of thoracic surgery 1992-11, Vol.54 (5), p.876-883
Hauptverfasser: Muehrcke, Derek D., Daggett, Willard M., Buckley, Mortimer J., Akins, Cary W., Hilgenberg, Alan D., Austen, W.Gerald
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Between June 1968 and April 1991, 75 patients who had undergone coronary angiography underwent repair of a postinfarction ventricular septal defect. Group 1 (n = 33) includes patients who had two- or three-vessel serious (>75% narrowing) proximal coronary artery disease and underwent complete revascularization in addition to repair of the ventricular septal defect. Group 2 (n = 19) patients also had two- or three-vessel coronary artery disease but bypass grafting was not performed; only the ventricular defect was repaired. Group 3 (n = 23) patients had only single-vessel coronary artery disease that corresponded to the region of the infarct; they underwent ventricular septal defect repair only. Follow-up of hospital survivors was 96% complete at a mean of 86.2 months (range, 1 to 288 months). Hospital mortality after ventricular septal defect repair was 21.2% in the cohort with bypassed coronary artery disease (group 1), 26.3% in those with unbypassed disease (group 2), and 26.1% in those with only single-vessel coronary artery disease (group 3) ( p = 0.88). With follow-up after 5 and 10 years, the actuarial survival was 72.2% ± 8% and 47.8% ± 10%, respectively, in the bypassed group, 29.2% ± 11% and 0%, respectively, in the unbypassed group, and 52.2% ± 10% and 36.5% ± 11%, respectively, in the cohort with single-vessel disease. Bypassing associated coronary artery disease significantly increased long-term survival when compared with patients with unbypassed coronary artery disease ( p = 0.0015).
ISSN:0003-4975
1552-6259
DOI:10.1016/0003-4975(92)90640-P